Joseph M Jenrette Iii is categorized under Physical Medicine, Physician/Surgeon in Charleston, SC and active since 2010.
Joseph M Jenrette Iii was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Joseph M Jenrette at the company’s single location by writing to 180 Calhoun St, Charleston, South Carolina SC 29401 or by phoning (843) 792-3271. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Joseph M Jenrette Iii |
Contact Person: | Joseph M Jenrette |
Address: | 180 Calhoun St, Charleston, South Carolina 29401 |
Phone Number: | (843) 792-3271 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Physical Medicine, Physician/Surgeon |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Joseph M Jenrette Iii was started in 2010 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joseph M Jenrette for inquiries that concern Joseph M Jenrette Iii by calling the company number (843) 792-3271, as your correspondence is most welcome. Additionally, the physical location of the single location of Joseph M Jenrette Iii can be found at the coordinates 32.784993,-79.939031 as well as the street address 180 Calhoun St in Charleston, South Carolina 29401.
For its online presence, you may visit Joseph M Jenrette Iii’s website at and engage with its social media outlets through on Twitter and on Facebook.